The questions people asked about GLP-1 medications a year ago: Do they work? Are they safe? has been answered. However, a new wave of questions is now emerging, and they're more complex, personal, and in some cases, more surprising than anyone had expected. Something has shifted in the conversation, and Holly and Jim are paying close attention.

When the questions change, that's where the real tension lives. People on these medications are reporting feeling emotionally flat. Others are quietly whispering that they're on drugs at all. Some are obsessing over microdosing, while still others are wondering if eliminating food noise entirely is actually a good thing. These aren't the questions of skeptics; they're the questions of people living with these medications every day. And the science hasn't fully caught up yet.

Join Holly and Jim as they walk through the new frontier of GLP-1 conversations. The ones happening in waiting rooms, on social media, and at dinner parties. This episode doesn't have all the answers, because honestly, no one does. But it will help you ask better questions.

Discussed on the episode:

The surprising effect of emotional flatness that keeps coming up, why it's not the same as depression, and what people actually mean by it.
What your brain's reward system has to do with gambling, alcohol, and your afternoon snack
The oral pill that's generating enormous buzz and the morning routine dealbreaker that comes with it
Why one of the world's leading researchers would personally choose the shot over the pill
The microdosing trend that’s taking over social media, and whether there's any real science behind it.
A thought-provoking question: Is there such a thing as too little food noise?
"Ozempic face," "Ozempic teeth," and the body changes that are really just weight loss in disguise.
Why some people are super responders and others barely respond at all, and what to do if you're in the second group
The reason people still whisper about being on these medications, and why Holly and Jim want that to stop
A big-picture concern about whether the medical model is crowding out the social one

The New GLP-1 Questions Nobody Saw Coming